Nordic Nanovector to Present Preclinical Data Demonstrating Betalutin® Reverses Resistance to Anti-CD20 Treatment in NHL Cells
Poster to be presented at Inaugural AACR International Meeting: Advances in Malignant Lymphoma
Page (1) of 1 - 06/11/18||
(June 11, 2018)
This article is no longer available,but here are some related topics.
HTN - Health Technology Net
DMN Newswire Newsletter
All Rights Reserved